{
  "main_header": {
    "sid": 184341,
    "name": "iSERA Lifescienc",
    "stock_name": "iSERA Lifescienc",
    "full_name": "iSERA Lifesciences Ltd",
    "name_url": "stocks-analysis/isera-lifescienc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "143.90",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "143.90",
    "mcapval": "354.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 534920,
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 67,
    "indexname": "India SENSEX",
    "isin": "INE899M01020",
    "curr_date": "Oct 08",
    "curr_time": "",
    "bse_nse_vol": "1.19 k",
    "exc_status": "Active",
    "traded_date": "Oct 08, 2026",
    "traded_date_str": "2026 10 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/isera-lifescienc-184341-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 15,
    "sid": "184341",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/isera-lifesciences-184341"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
      "datetime": "08-Oct-2026",
      "details": "Disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations 2015 - Continual Disclosure consequent to Preferential Allotment of Equity Shares on a Share Swap Basis",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "07-Oct-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Archana Lonkar",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "07-Oct-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Nandkumar Kadam",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "iSERA Lifesciences Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 13",
          "dt": "2013-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "iSERA Lifesciences Ltd has announced <strong>25:1</strong> rights issue, ex-date: 24 Oct 25",
          "dt": "2025-10-24",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

No Recent News for the Company

View All News